Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Smart Safes Can Help Ease the Burden of Handling Cash in Medical Clinics

The American healthcare system is evolving. Patients are increasingly receiving service from a number of small, standalone facilities such as urgent care clinics, diagnostic centers, dialysis clinics, and ambulatory surgical centers. To effectively serve their patients, this rapidly growing segment of the healthcare sector needs to evolve as well, particularly in the ways they deal with cash…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The American healthcare system is evolving. Patients are increasingly receiving service from a number of small, standalone facilities such as urgent care clinics, diagnostic centers, dialysis clinics, and ambulatory surgical centers. To effectively serve their patients, this rapidly growing segment of the healthcare sector needs to evolve as well, particularly in the ways they deal with cash as part of their day-to-day operations. By using smart safes, these vital healthcare facilities can reduce concerns about cash losses and theft so they can concentrate on what’s truly important – caring for their patients.

Demand for Urgent Care Clinics is Growing Rapidly

According to Laurel Stoimenoff, CEO of the Urgent Care Association, the number of clinics in the U.S. grew from 6,946 in 2015 to 8,285 as of June 2018. Urgent care clinics handle about 89 million patient visits each year – almost 30% of all primary care visits in the country. Patients appreciate the increased convenience, faster service, and lower costs offered by these smaller facilities. A recent study of the costs of care in freestanding emergency departments, hospital emergency departments, and urgent care centers found the average price-per-visit for Texas-based urgent care clinics was just $168 in 2015, compared to $2,259 for hospital-based emergency department visits and $2,199 for freestanding emergency care clinics.

Many Patients Prefer to Pay for Their Healthcare with Cash

 Despite the growth of credit cards and other electronic payment methods, a significant segment of the U.S. population still prefers to pay for goods and services in cash. Many patients are finding that they can even receive substantial discounts when they pay for their medical care in cash. The Wall Street Journal, for example, recently shared the story of a patient who received an X-ray for $70 by paying cash upfront instead of the $600 it would cost her by submitting a claim using her high-deductible insurance policy. This cash option may increasingly appeal to patients as many are enrolled in high deductible insurance plans where they pay for more of their medical services out of pocket. This trend benefits urgent care centers, as well. If a patient is willing to pay at the point of service, the urgent care center receives the funds immediately instead of waiting 30 to 60 days for a claim to be processed with an insurance company.

Smart Safes Eliminate the Need for Clinics to Manually Handle Cash

The main priority of front office personnel, healthcare professionals, and administrative staff should be patient care, not dealing with how to handle payments, particularly those that are facilitated with cash. Without a proven solution, daily cash volumes at healthcare clinics can lead to challenges that can be difficult to overcome. Smart safes can help relieve the burden of manually managing cash, allowing these facilities to reallocate staff to more important tasks rather than spending hours counting and reconciling cash payments, and chasing down missing funds. In addition, smart safes give clinics access to a rich suite of real-time data to effectively run a business at scale. With this burden removed, healthcare staffs place themselves in a better position to serve their clients.

Tidel is addressing the cash management needs of the ever-changing healthcare landscape. Our systems have been deployed in several healthcare organizations who have realized the dramatic efficiencies and accountability that a proven cash management system provides. Tidel solutions help secure and automate a cash business, alleviate worry, and allow providers to focus on patient care. To find out more, visit https://www.tidel.com/targetmarket/healthcare/.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512